Conavi Medical (TSXV:CNVI) has announced that the Journal of the American College of Cardiology: Cardiovascular Interventions (JACC) has published a peer-reviewed article detailing recent advances in hybrid intracoronary imaging.
The JACC paper explores the clinical and research potential of hybrid intracoronary imaging across several areas, including percutaneous coronary intervention (PCI) guidance, vulnerable plaque detection, and evaluating focal and systemic therapies targeting atherosclerosis.
“The publication of this article comes at an opportune time as we showcase our Novasight Hybrid System at the Cardiovascular Research Foundation’s annual Transcatheter Cardiovascular Therapeutics (TCT) conference taking place now in Washington, DC,” said Tom Looby, CEO of Conavi Medical. “We would like to take this opportunity to thank Drs. Tufaro and Bourantas, as well as their esteemed colleagues who have contributed to the growing awareness and adoption of hybrid imaging in the care of coronary patients, and look forward to continuing to build on that positive momentum as we progress.”
Christos V. Bourantas, MD, Ph.D., a consultant cardiologist at Barts Heart Centre and Professor of Cardiology (Hon) at Queen Mary University London, and one of the article’s authors, commented, “There is a large and growing body of evidence that the use of OCT or IVUS to guide PCI procedures has substantially improved patient event-free survival, enhancing both the long-term safety and effectiveness of the procedure. However, each imaging modality has unique advantages and limitations. Conavi Medical’s Novasight Hybrid System offers an elegant solution, providing simultaneous and complementary data with which to better inform patient care.”
